Mesenchymal Stem Cell: Present Challenges and Prospective Cellular Cardiomyoplasty Approaches for Myocardial Regeneration
- 1 August 2009
- journal article
- review article
- Published by Mary Ann Liebert Inc in Antioxidants and Redox Signaling
- Vol. 11 (8), 1841-1855
- https://doi.org/10.1089/ars.2009.2455
Abstract
Myocardial ischemia and cardiac dysfunction have been known to follow ischemic heart diseases (IHDs). Despite a plethora of conventional treatment options, their efficacies are associated with skepticism. Cell therapies harbor a promising potential for vascular and cardiac repair, which is corroborated by adequate preclinical evidence. The underlying objectives behind cardiac regenerative therapies subsume enhancing angiomyogenesis in the ischemic myocardium, ameliorating cellular apoptosis, regenerating the damaged myocardium, repopulating the lost resident myocardial cells (smooth muscle, cardiomyocyte, and endothelial cells), and finally, decreasing fibrosis with a consequent reduction in ventricular remodeling. Although-cell based cardiomyoplasty approaches have an immense potential, their clinical utilization is limited owing to the increased need for better candidates for cellular cardiomyoplasty, better routes of delivery, appropriate dose for efficient engraftment, and better preconditioning or genetic-modification strategies for the progenitor and stem cells. Mesenchymal stem cells (MSCs) have emerged as powerful candidates in mediating myocardial repair owing to their unique properties of multipotency, transdifferentiation, intercellular connection with the resident cardiomyocytes via connexin 43 (Cx43)-positive gap junctions in the myocardium, and most important, immunomodulation. In this review, we present an in-depth discussion on the complexities associated with stem and progenitor cell therapies, the potential of preclinical approaches involving MSCs for myocardial repair, and an account of the past milestones and ongoing MSC-based trials in humans. Antioxid. Redox Signal. 11, 1841–1855.Keywords
This publication has 144 references indexed in Scilit:
- Human embryonic stem cells and cardiac repairTransplantation Reviews, 2009
- Granulocyte colony-stimulating factor therapy for cardiac repair after acute myocardial infarction: A systematic review and meta-analysis of randomized controlled trialsAmerican Heart Journal, 2008
- Pre-Treatment of Mesenchymal Stem Cells With a Combination of Growth Factors Enhances Gap Junction Formation, Cytoprotective Effect on Cardiomyocytes, and Therapeutic Efficacy for Myocardial InfarctionJournal of the American College of Cardiology, 2008
- Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardiumJournal of Molecular and Cellular Cardiology, 2008
- Generation of human induced pluripotent stem cells from dermal fibroblastsProceedings of the National Academy of Sciences of the United States of America, 2008
- Human cardiac stem cellsProceedings of the National Academy of Sciences of the United States of America, 2007
- Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined FactorsCell, 2006
- Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarctionNature Medicine, 2006
- Adult bone marrow–derived cells: Regenerative potential, plasticity, and tissue commitmentBasic Research in Cardiology, 2005
- Therapeutic stem and progenitor cell transplantation for organ vascularization and regenerationNature Medicine, 2003